What is central pontine myelinolysis (CPM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To prevent myelinolysis, sodium correction should be limited to 6-8 mEq/L per 24 hours in high-risk patients, such as those with severe hyponatraemia, as rapid correction can lead to central pontine myelinolysis, as highlighted in the management of autoimmune encephalitis patients 1. When managing patients with severe hyponatraemia, it is crucial to avoid rapid correction of sodium levels to prevent myelinolysis.

  • Controlled slow correction of sodium levels is essential in patients with severe hyponatraemia to avoid central pontine myelinolysis, as stated in the study on autoimmune encephalitis 1.
  • In most cases, hyponatraemia is related to inappropriate antidiuretic hormone secretion, and fluid restriction is sufficient, as noted in the study 1.
  • The study emphasizes the importance of careful monitoring and management of blood pressure and heart rate fluctuations in patients with severe dysautonomia, which can be associated with hyponatraemia and myelinolysis 1. Key considerations in preventing myelinolysis include:
  • Identifying high-risk patients, such as those with chronic hyponatremia, alcoholism, malnutrition, or liver disease
  • Limiting sodium correction to 6-8 mEq/L per 24 hours
  • Using hypertonic saline for severe hyponatremia or fluid restriction for milder cases
  • Frequent monitoring of serum sodium levels to avoid rapid changes in osmolality, as recommended in the context of autoimmune encephalitis management 1.

From the Research

Myelinolysis Overview

  • Myelinolysis is a neurological disorder characterized by damage to the myelin and oligodendrocytes in the pons, often associated with rapid correction of hyponatremia 2.
  • The condition can display diverse psychiatric symptoms, with electrolyte imbalance, alcoholism, and malnutrition being frequent causes 3.

Causes and Risk Factors

  • Rapid correction of hyponatremia is a known cause of myelinolysis, with a recommended increase in plasma sodium concentration of no more than 8 to 10 mmol/L per 24 h in chronic hyponatremia 2.
  • Severe hyponatremia correction rates are frequently limited in patients to prevent neurologic complications, but the implications of correction rates on overall mortality and length of hospital stay are unclear 4.
  • Animal models have demonstrated the role of rapid correction of hyponatremia as causative of pontine and extrapontine myelinolytic lesions 5, 2.

Treatment and Prevention

  • Myoinositol administration has been shown to improve survival and reduce myelinolysis after rapid correction of chronic hyponatremia in rats 6.
  • Limiting the sodium correction rate has been associated with higher mortality and longer length of stay, highlighting the need for careful management of hyponatremia correction 4.
  • Psychiatrists should be meticulous in excluding organic causes in first-episode mania and consider myelinolysis in the differential diagnosis for the pertinent patient group 3.

Clinical Presentation

  • Myelinolysis can present with diverse psychiatric symptoms, including manic episodes, and may be triggered by rapid correction of hyponatremia 3.
  • The condition can also present with neurological deterioration, including damage to the myelin and oligodendrocytes in the pons 5, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Central pontine myelinolysis secondary to rapid correction of hyponatremia historical perspective with Doctor Robert Laureno.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.